Advanced disease* | Death | Total n= | |
Number of patients | 340 | 144 | 484 |
Baseline biospecimens | 333 | 139 | 472 |
Biospecimens year 1–4 | 357 | 79 | 436 |
QoL baseline | 325 | 133 | 458 |
QoL year 1–4 | 441 | 93 | 534 |
*Advanced disease: includes metastatic disease and castration resistant prostate cancer.
APCaRI, Alberta Prostate Cancer Research Initiative; PROM, patient-reported outcome measures; QoL, quality of life.